BlueOcean NutraSciences CEO Transition.
Saved in:
| Title: | BlueOcean NutraSciences CEO Transition. |
|---|---|
| Authors: | Marketwired |
| Source: | Marketwire (English). 08/05/2014. |
| Abstract: | TORONTO, ONTARIO -- (Marketwired) -- 08/05/14 -- The Board of Directors of BlueOcean NutraSciences (TSX VENTURE: BOC) announce the appointment of Mr. Gavin Bogle as BlueOceans' interim CEO effective immediately, replacing Doug Kemp-Welch who will stay as an Advisor until September 8, 2014. Mr. Bogle will remain a director of BlueOcean. Gavin will lead BlueOcean in the next phase of its development after Doug repositioned the company as a specialty producer of oils for the nutraceutical and pharmaceutical industries. [ABSTRACT FROM PUBLISHER] |
| Database: | Newspaper Source Plus |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | TORONTO, ONTARIO -- (Marketwired) -- 08/05/14 -- The Board of Directors of BlueOcean NutraSciences (TSX VENTURE: BOC) announce the appointment of Mr. Gavin Bogle as BlueOceans' interim CEO effective immediately, replacing Doug Kemp-Welch who will stay as an Advisor until September 8, 2014. Mr. Bogle will remain a director of BlueOcean. Gavin will lead BlueOcean in the next phase of its development after Doug repositioned the company as a specialty producer of oils for the nutraceutical and pharmaceutical industries. [ABSTRACT FROM PUBLISHER] |
|---|
